Limelight Lab Grown Diamonds plans to open 25 new retail stores in the first quarter of fiscal year 2026 [1].
The expansion signals a strategic push to capture the growing demand for sustainable and affordable jewelry among younger Indian consumers. By scaling its physical presence, the company aims to capitalize on a market shift where ethical sourcing and lower price points are driving consumer behavior.
Backed by an $11 million capital raise [2], the company intends to reach a total of 100 stores across India by 2026 [2]. The initial growth phase will focus on major metropolitan hubs, including Mumbai, Delhi, and Bengaluru [2].
"We are excited to accelerate our retail footprint across India and add 25 new stores in the first quarter of FY26," the CEO of Limelight Lab Grown Diamonds said [3].
The company is entering the market at a time of significant volatility for lab-grown diamonds. Some industry reports suggest the sector is reshaping the jewelry world through rapid growth and affordability [4]. However, other analysts warn that a glut of supply could cause prices to tumble as the initial boom ends [5].
Despite these market contradictions, the price advantage remains a primary driver. Lab-grown diamonds currently cost 73% less than natural diamonds [6]. This pricing gap has already shifted preferences in other markets, where lab-grown options account for more than 45% of engagement ring purchases in the U.S. [6].
"The addition of 25 stores will cement our leadership in India's fast-growing LGD segment," the Head of Retail for Limelight Lab Grown Diamonds said [7].
Other players in the region are also seeking aggressive growth. Dholakia Lab Grown Diamond recently raised ₹800 crore to lead the segment [8]. This trend suggests a broader corporate race to establish dominance in the Indian lab-grown diamond market before potential price corrections occur.
“Limelight intends to reach a total of 100 stores across India by 2026.”
The aggressive expansion of Limelight and Dholakia suggests that the Indian jewelry market is hitting a tipping point where lab-grown diamonds are moving from a niche alternative to a mainstream commodity. While the capital influx shows strong investor confidence, the contradiction between rapid retail growth and warnings of a supply-driven price collapse indicates a high-risk, high-reward environment. The outcome will likely depend on whether consumer demand among the youth can outpace the increasing volume of synthetic diamond production.
